Deching Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deching Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deching Capital Today - Breaking & Trending Today

With Phase 3 Studies Ongoing in Bladder Cancer, CG Oncology Plots Course for IPO

Published: January 7, 2024

CG Oncology’s main asset is cretostimogene, an oncolytic virus in late-stage development as a treatment for advanced bladder cancer. The IPO filing follow the report of interim efficacy data showing a 75% complete response rate.

Source: medcitynews.com

Related Topics:

United StatesExchange CommissionRenaissance CapitalBacillus Calmette GuUrologic OncologyCold GenesysDeching CapitalWeight LossMedical DevicesHealthcare InnovationMedcity NewsMedcity NewsSan FranciscoLife SciencesRock HealthStartup AdviceStartup FundingPatient Monitoring SystemOtion SensorsHealthcare ItFoodborne PathogensIagnostics CompanyIagnostic PlatformsMinimally Invasive SurgeryAser Surgery